Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Cardiac epithelial-mesenchymal transition is blocked by monomethylarsonous acid (III).

Authors: Huang, Tianfang; Barnett, Joey V; Camenisch, Todd D

Published In Toxicol Sci, (2014 Nov)

Abstract: Arsenic exposure during embryonic development can cause ischemic heart pathologies later in adulthood which may originate from impairment in proper blood vessel formation. The arsenic-associated detrimental effects are mediated by arsenite (iAs(III)) and its most toxic metabolite, monomethylarsonous acid [MMA (III)]. The impact of MMA (III) on coronary artery development has not yet been studied. The key cellular process that regulates coronary vessel development is the epithelial-mesenchymal transition (EMT). During cardiac EMT, activated epicardial progenitor cells transform to mesenchymal cells to form the cellular components of coronary vessels. Smad2/3 mediated TGFβ2 signaling, the key regulator of cardiac EMT, is disrupted by arsenite exposure. In this study, we compared the cardiac toxicity of MMA (III) with arsenite. Epicardial progenitor cells are 15 times more sensitive to MMA (III) cytotoxicity when compared with arsenite. MMA (III) caused a significant blockage in epicardial cellular transformation and invasion at doses 10 times lower than arsenite. Key EMT genes including TGFβ ligands, TβRIII, Has2, CD44, Snail1, TBX18, and MMP2 were down regulated by MMA (III) exposure. MMA (III) disrupted Smad2/3 activation at a dose 20 times lower than arsenite. Both arsenite and MMA (III) significantly inhibited Erk1/2 and Erk5 phosphorylation. Nuclear translocation of Smad2/3 and Erk5 was also blocked by arsenical exposure. However, p38 activation, as well as smooth muscle differentiation, was refractory to the inhibition by the arsenicals. Collectively, these findings revealed that MMA (III) is a selective disruptor of cardiac EMT and as such may predispose to arsenic-associated cardiovascular disorders.

PubMed ID: 25145660 Exiting the NIEHS site

MeSH Terms: Animals; Arsenites/toxicity*; Cell Culture Techniques; Cell Line; Cell Survival/drug effects; Coronary Vessels/drug effects*; Coronary Vessels/embryology; Coronary Vessels/metabolism; Coronary Vessels/pathology; Epithelial-Mesenchymal Transition/drug effects*; Epithelial-Mesenchymal Transition/genetics; Gene Expression Regulation, Developmental/drug effects; Mice, Transgenic; Organogenesis/drug effects; Organogenesis/genetics; Organometallic Compounds/toxicity*; Pericardium/drug effects*; Pericardium/embryology; Pericardium/metabolism; Pericardium/pathology; Stem Cells/drug effects; Stem Cells/metabolism; Stem Cells/pathology

Back
to Top